Target intelligence / Profile preview

Poly(A) polymerase gamma (PAPOLG)

Target
PAPOLG
Molecular classification
Enzyme, Transferase
01

Overview

Poly(A) polymerase gamma (PAPOLG) is a nuclear enzyme in the poly(A) polymerase family responsible for the post-transcriptional adenylation of the 3'-end of mRNA precursors and several small RNAs, including signal recognition particle (SRP) RNA, nuclear 7SK RNA, U2 small nuclear RNA, and ribosomal 5S RNA[1][2][8]. PAPOLG catalyzes the template-independent addition of adenosine monophosphate residues, a modification important for RNA processing and stability. It shares about 60% amino acid identity with poly(A) polymerase II (PAPII) and localizes exclusively to the nucleus. PAPOLG exhibits both nonspecific and CPSF/AAUAAA-dependent polyadenylation activity[1][2]. Defects or deletions affecting PAPOLG are associated with rare genetic syndromes and acute cystitis, but there are no direct indications of approved or investigational drugs targeting this enzyme, nor clinical biomarkers or specific safety concerns documented to date[1].

Other names
Poly(A) polymerase gammaPAPOLGPAP2PAPGPAP-gammaNeo-PAPSRP RNA-adenylating enzymeFLJ12972Neo-poly(A) polymerasePolynucleotide adenylyltransferase gammaSRP RNA 3'-adenylating enzymeSignal recognition particle RNA-adenylating enzymenuclear poly(A) polymerase gammasignal recognition particle RNA-adenylating enzymepap2
02

Biological functions

mRNA processingRNA 3'-end processingpost-transcriptional adenylationRNA binding
03

Disease associations

Chromosome 2p16.1-p15 deletion syndromeAcute cystitisOther

Beyond the preview

Go deeper on Poly(A) polymerase gamma (PAPOLG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Poly(A) polymerase gamma (PAPOLG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call